down arrow

FDC

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE258B01022
  • NSEID: FDC
  • BSEID: 531599
INR
425.20
18.05 (4.43%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.02 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

409.30425.55

52 Week

358.95659.00
Valuation
Technical
Day's Volume

CASH

1.02 lacs (18.27%) Volume

Shareholding (Dec 2024)

FII

2.67%

Held by 100 FIIs

DII

6.08%

Held by 9 DIIs

Promoter

69.66%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 10.15% and Operating profit at 2.12% over the last 5 years

 
2

Negative results in Dec 24

3

Stock is technically in a Bearish range

4

With ROE of 13.8, it has a Expensive valuation with a 2.9 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 6,923 Cr (Mid Cap)

stock-summary
P/E

24.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

1.23%

stock-summary
Debt Equity

-0.25

stock-summary
Return on Equity

13.81%

stock-summary
Price to Book

2.89

Revenue and Profits (1 Year):
Net Sales:
464 Cr
(Quarterly Results - Dec 2024)
Net Profit:
37 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (1.23%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.26%
0.96%
-19.3%
1 Year
-5.7%
1.12%
-4.58%
2 Years
59.79%
1.65%
61.44%
3 Years
51.05%
2.05%
53.1%
4 Years
37.52%
1.50%
39.02%
5 Years
77.2%
2.08%
79.28%

Latest dividend: 5 per share ex-dividend date: Nov-22-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
10.15%
EBIT Growth (5y)
2.12%
EBIT to Interest (avg)
66.85
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.84
Tax Ratio
25.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
8.75%
ROCE (avg)
19.72%
ROE (avg)
13.70%
Valuation key factors
Factor
Value
P/E Ratio
24
Industry P/E
33
Price to Book Value
2.89
EV to EBIT
22.34
EV to EBITDA
18.95
EV to Capital Employed
3.52
EV to Sales
2.92
PEG Ratio
NA
Dividend Yield
1.23%
ROCE (Latest)
18.11%
ROE (Latest)
13.81%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 9 Schemes (5.87%)

FIIs

Held by 100 FIIs (2.67%)

Promoter with highest holding

Nomita R Chandavarkar (22.67%)

Highest Public shareholder

Nippon Life India Trustee Ltd-a/c Nippon India Small Cap Fund (2.61%)

Individual Investors Holdings

16.57%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -9.68% vs -19.49% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is -48.58% vs -39.48% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "464.11",
          "val2": "513.85",
          "chgp": "-9.68%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "46.65",
          "val2": "70.16",
          "chgp": "-33.51%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.95",
          "val2": "1.07",
          "chgp": "-11.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37.04",
          "val2": "72.04",
          "chgp": "-48.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.05%",
          "val2": "13.65%",
          "chgp": "-3.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 12.65% vs 8.84% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 6.33% vs 46.61% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,152.12",
          "val2": "1,022.74",
          "chgp": "12.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "216.79",
          "val2": "198.42",
          "chgp": "9.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.37",
          "val2": "2.11",
          "chgp": "12.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "191.08",
          "val2": "179.71",
          "chgp": "6.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "18.82%",
          "val2": "19.40%",
          "chgp": "-0.58%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 9.14% vs 9.78% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -11.90% vs 58.54% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,616.23",
          "val2": "1,480.91",
          "chgp": "9.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "263.44",
          "val2": "282.21",
          "chgp": "-6.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.32",
          "val2": "3.08",
          "chgp": "7.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "228.12",
          "val2": "258.94",
          "chgp": "-11.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "16.30%",
          "val2": "19.06%",
          "chgp": "-2.76%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 8.92% vs 16.74% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 57.30% vs -10.33% in Mar 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,942.94",
          "val2": "1,783.75",
          "chgp": "8.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "338.54",
          "val2": "250.97",
          "chgp": "34.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.03",
          "val2": "4.09",
          "chgp": "-1.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "305.22",
          "val2": "194.04",
          "chgp": "57.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "17.42%",
          "val2": "14.07%",
          "chgp": "3.35%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
464.11
513.85
-9.68%
Operating Profit (PBDIT) excl Other Income
46.65
70.16
-33.51%
Interest
0.95
1.07
-11.21%
Exceptional Items
0.00
0.00
Consolidate Net Profit
37.04
72.04
-48.58%
Operating Profit Margin (Excl OI)
10.05%
13.65%
-3.60%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is -9.68% vs -19.49% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is -48.58% vs -39.48% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,152.12
1,022.74
12.65%
Operating Profit (PBDIT) excl Other Income
216.79
198.42
9.26%
Interest
2.37
2.11
12.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
191.08
179.71
6.33%
Operating Profit Margin (Excl OI)
18.82%
19.40%
-0.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 12.65% vs 8.84% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is 6.33% vs 46.61% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,616.23
1,480.91
9.14%
Operating Profit (PBDIT) excl Other Income
263.44
282.21
-6.65%
Interest
3.32
3.08
7.79%
Exceptional Items
0.00
0.00
Consolidate Net Profit
228.12
258.94
-11.90%
Operating Profit Margin (Excl OI)
16.30%
19.06%
-2.76%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 9.14% vs 9.78% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -11.90% vs 58.54% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
1,942.94
1,783.75
8.92%
Operating Profit (PBDIT) excl Other Income
338.54
250.97
34.89%
Interest
4.03
4.09
-1.47%
Exceptional Items
0.00
0.00
Consolidate Net Profit
305.22
194.04
57.30%
Operating Profit Margin (Excl OI)
17.42%
14.07%
3.35%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 8.92% vs 16.74% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 57.30% vs -10.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About FDC Ltd stock-summary
stock-summary
FDC Ltd
Mid Cap
Pharmaceuticals & Drugs
FDC Limited is a fully integrated, research-oriented pharmaceutical company engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs). FDC's formulation department designs and develops products for various global markets and the highly regulated markets of US and Europe. The company has built a visible presence in the Regulated and Emerging markets.
Company Coordinates stock-summary
Company Details
B-8 MIDC Industrial Area, Waluj Dist Aurangabad (Maharashtra) Maharashtra : 431136
stock-summary
Tel: 91-240-2554407/967/299
stock-summary
http://www.fdcindia.com
stock-summary
investors@fdcindia.com
Registrar Details
Sharex Dynamic (India) Pvt Ltd , Unit -1, Luthra Ind. Premises , Safed Pool, Andheri-Kurla Road, Andheri (E), Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."